🔗 Share this article Social Media Influencers Fueling Parallel Trade for Unapproved Weight-Loss Drug A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations. Investigational Drug Gaining Popularity Via Social Media Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these accounts privately for source information, while also obtaining discount codes. Thriving Commerce on Social Networks Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the substance there before directing buyers to other platforms for purchases. Learning About The Experimental Drug Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic. Medical Experts Voice Worries However, doctors and pharmacists have warned that the distribution of what is still an unapproved drug in the UK is worrisome and could result in users administering substances of uncertain source. Some professionals said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro. Regulatory Position and Implementation Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012. Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment. Service Response and Material Elimination According to the social media company, the platform has taken down violative content and banned associated keywords and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing compliance measures. Digital Trading Operations Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence. After minutes of joining one community, a seller posted contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or previous experience. Item Details and Pricing Within these communities, messages show dark colored packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.” Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”. Platform Moderation and Safety Measures A representative for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”. Medical Professional Cautions “People are injecting materials they can’t verify. Although the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U. A medical professional of Asda Online Doctor linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said. Her team has previously seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.” Producer Statement A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject users to possibly serious medical dangers”.